aluminum has been researched along with Parkinson Disease in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (40.54) | 18.7374 |
| 1990's | 11 (29.73) | 18.2507 |
| 2000's | 2 (5.41) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 7 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Exley, C; Mold, MJ | 1 |
| Bianchi, AR; Capriello, T; De Maio, A; Di Meglio, G; Ferrandino, I; Giarra, A; Scudiero, R; Toscanesi, M; Trifuoggi, M | 1 |
| Aragão, WAB; Baia-da-Silva, DC; Cirovic, A; de Lima, WF; Eiró-Quirino, L; Lima, RR; Né, YGS | 1 |
| Baj, J; Bryliński, Ł; Buszewicz, G; Duda, P; Flieger, J; Góra, J; Granat, M; Kostelecka, K; Sitarz, R; Teresiński, G; Woliński, F | 1 |
| Exley, C; Mold, MJ; Morris, B; O'Farrell, A | 1 |
| Adam, H; Arshad, MKM; Gopinath, SCB; Hashim, U; Parmin, NA | 1 |
| Khudoerkov, RM; Salkov, VN | 1 |
| Ahmed, SS; Santosh, W | 1 |
| Chimedregzen, U; Kagawa, Y; Kaneko, Y; Kawabata, T; Komatsu, F; Otgon, J; Purvee, B | 1 |
| Yokel, RA | 1 |
| Kihira, T; Yase, Y; Yoshida, S | 1 |
| Fiori, CE; Fukatsu, R; Gajdusek, DC; Garruto, RM; Hook, G; Yanagihara, R | 1 |
| Iwata, S; Mizumoto, Y; Sasajima, K; Yase, Y; Yoshimasu, F | 1 |
| Atadzhanov, M | 1 |
| Gajdusek, DC; Garruto, RM; Gibbs, CJ; Perl, DP; Yanagihara, RT | 1 |
| Hayashi, S; Higashi, Y; Kita, S; Miyamoto, K; Miyoshi, K; Nagasaki, Y; Ogura, Y; Uebayashi, Y; Yase, Y; Yasui, M; Yoshimasu, F | 1 |
| Chen, WH; Kao, HJ; Liu, JS | 1 |
| Altschuler, E | 1 |
| Milanese, M; Zambenedetti, P; Zatta, P | 1 |
| Duckett, S; Galle, P; Kradin, R | 1 |
| Duckett, S; Escourolle, R; Galle, P; Grey, F | 1 |
| Good, PF; Olanow, CW; Perl, DP | 1 |
| Kihira, T; Ota, K; Yasui, M | 1 |
| Good, PF; Perl, DP | 1 |
| Adachi, K; Kihira, T; Mukoyama, M; Ota, K; Yasui, M | 1 |
| de Wolff, FA; Marani, E; Tio, S; van der Voet, GB | 1 |
| Deloncle, R; Guillard, O | 1 |
| Agid, Y; Brandel, JP; Galle, P; Hirsch, EC; Javoy-Agid, F | 1 |
| Harrison, PJ | 1 |
| Gajdusek, DC; Garruto, RM; Gibbs, CJ; Piccardo, P; Yanagihara, R | 1 |
| Ganrot, PO | 1 |
| Fiori, CE; Gajdusek, DC; Garruto, RM; Swyt, C; Yanagihara, R | 1 |
| Pendlebury, WW; Perl, DP | 1 |
| Muenter, MD; Owen, CA; Sharpless, NS; Tyce, GM | 1 |
| Hirano, A; Terry, RD; Wiśniewski, H | 1 |
| Eichhorn, F; Kott, E; Rutenberg, A | 1 |
| Bannow, RE; Fincham, RW; Routh, JI; Stoll, JL | 1 |
7 review(s) available for aluminum and Parkinson Disease
| Article | Year |
|---|---|
Aluminium in the Human Brain: Routes of Penetration, Toxicity, and Resulting Complications.
Topics: Aluminum; Alzheimer Disease; Autism Spectrum Disorder; Brain; Central Nervous System; Humans; Multiple Sclerosis; Parkinson Disease | 2023 |
Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration.
Topics: Aluminum; Alzheimer Disease; Basement Membrane; Blood-Brain Barrier; Brain; Copper; Humans; Iron; Manganese; Membrane Transport Proteins; Mercury; Nerve Degeneration; Parkinson Disease; Zinc | 2006 |
[Modeling parkinsonism (review)].
Topics: Aluminum; Animals; Carbachol; Cats; Caudate Nucleus; Chlorides; Chlorpromazine; Disease Models, Animal; Globus Pallidus; Humans; Hydroxydopamines; Manganese; Manganese Compounds; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Putamen; Rabbits; Rats; Red Nucleus; Reserpine; Substantia Nigra; Syndrome; Tetanus Toxin; Thalamus; Tungsten; Tungsten Compounds | 1982 |
Aluminum, Alzheimer's disease, and the olfactory system.
Topics: Aluminum; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Brain; Dementia; Humans; Nasal Cavity; Neurofibrillary Tangles; Neurons; Olfactory Pathways; Parkinson Disease | 1991 |
Aluminium neurotoxicity.
Topics: Aluminum; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Culture Techniques; Dementia; Humans; Immunohistochemistry; Nervous System; Nervous System Diseases; Parkinson Disease; Renal Dialysis | 1991 |
Mechanism of Alzheimer's disease: arguments for a neurotransmitter-aluminium complex implication.
Topics: Aluminum; Alzheimer Disease; Blood-Brain Barrier; Brain; Down Syndrome; Humans; Neurotransmitter Agents; Parkinson Disease | 1990 |
Metabolism and possible health effects of aluminum.
Topics: Actin Cytoskeleton; Aluminum; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Aneuploidy; Animals; Autoimmune Diseases; Beryllium; Biological Transport; Bone and Bones; Brain; Cations; Cell Division; Cells; Chromium; Connective Tissue; Cytoplasm; DNA; Down Syndrome; Encephalitis; Erythrocytes; Feces; Gallium; Humans; Hypersensitivity; Immunity, Cellular; Indium; Intestinal Absorption; Intestinal Mucosa; Lung; Membrane Lipids; Microtubules; Muscular Dystrophies; Nondisjunction, Genetic; Osteomalacia; Parkinson Disease; Renal Dialysis; Scandium; Tissue Distribution; Transferrin; Yttrium; Zirconium | 1986 |
30 other study(ies) available for aluminum and Parkinson Disease
| Article | Year |
|---|---|
Aluminium co-localises with Biondi ring tangles in Parkinson's disease and epilepsy.
Topics: Aged; Aluminum; Choroid Plexus; Epilepsy; Female; Humans; Immunohistochemistry; Intranuclear Inclusion Bodies; Male; Microscopy, Fluorescence; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Tomography, X-Ray Computed | 2022 |
Aluminium exposure leads to neurodegeneration and alters the expression of marker genes involved to parkinsonism in zebrafish brain.
Topics: Aluminum; Animals; Biomarkers; Brain; Glial Fibrillary Acidic Protein; Mammals; Neurodegenerative Diseases; Neurotoxicity Syndromes; Parkinson Disease; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Zebrafish | 2022 |
Global Scientific Research Landscape on Aluminum Toxicology.
Topics: Aluminum; Alzheimer Disease; Bibliometrics; Humans; Parkinson Disease; Research Design | 2023 |
Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
Topics: Aged, 80 and over; Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Brain; Epilepsy; Humans; Male; Middle Aged; Neurofibrillary Tangles; Neurons; Parkinson Disease; Phosphorylation; Presenilin-1; tau Proteins | 2020 |
Distinguishing normal and aggregated alpha-synuclein interaction on gold nanorod incorporated zinc oxide nanocomposite by electrochemical technique.
Topics: alpha-Synuclein; Aluminum; Electrochemical Techniques; Electrodes; Gold; Humans; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Nanocomposites; Nanotubes; Parkinson Disease; Particle Size; Protein Aggregates; Sensitivity and Specificity; Surface Properties; Zinc Oxide | 2021 |
[The role of aluminum and lead in the development of Alzheimer's and Parkinson's diseases].
Topics: alpha-Synuclein; Aluminum; Alzheimer Disease; Histones; Humans; Parkinson Disease | 2021 |
Metallomic profiling and linkage map analysis of early Parkinson's disease: a new insight to aluminum marker for the possible diagnosis.
Topics: Aluminum; Analysis of Variance; Biomarkers; Case-Control Studies; Genetic Linkage; Humans; Mass Spectrometry; Parkinson Disease | 2010 |
A high accumulation of hair minerals in Mongolian people: 2(nd) report; influence of manganese, iron, lead, cadmium and aluminum to oxidative stress, Parkinsonism and arthritis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aluminum; Arthritis; Cadmium; Case-Control Studies; Child; Female; Hair; Humans; Iron; Japan; Lead; Male; Manganese; Middle Aged; Minerals; Mongolia; Oxidative Stress; Parkinson Disease; Poaceae; Prevalence; Soil; Water; Young Adult | 2011 |
[Etiology of Kii ALS/PDC, featuring a mineral hypothesis].
Topics: Aluminum; Amyotrophic Lateral Sclerosis; Calcium; Dementia; Female; Humans; Japan; Magnesium Deficiency; Male; Parkinson Disease | 2007 |
Imaging of calcium and aluminum in neurofibrillary tangle-bearing neurons in parkinsonism-dementia of Guam.
Topics: Aged; Aluminum; Calcium; Cytoskeleton; Guam; Hippocampus; Humans; Middle Aged; Parkinson Disease | 1984 |
[Reactor neutron activation analysis for aluminium in the presence of phosphorus and silicon. Contributions of 28Al activities from 31P(n, alpha) 28Al and 28Si(n, p) 28Al reactions].
Topics: Activation Analysis; Aluminum; Aluminum Compounds; Aluminum Silicates; Amyotrophic Lateral Sclerosis; Brain Chemistry; Humans; Neutron Activation Analysis; Parkinson Disease; Phosphates; Radioisotopes; Spinal Cord | 1984 |
Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam.
Topics: Aged; Aluminum; Amygdala; Cell Nucleus; Cytoplasm; Dementia; Female; Guam; Humans; Hypothalamus; Male; Middle Aged; Neurofibrils; Neurons; Parkinson Disease; Sclerosis; Spectrometry, X-Ray Emission | 1982 |
[Generalized amyloidosis: increased aluminum in CNS and other organ tissue (author's transl)].
Topics: Aluminum; Amyloidosis; Central Nervous System; Humans; Male; Middle Aged; Parkinson Disease; Tissue Distribution | 1980 |
Rapid progression of parkinsonism associated with an increase of blood manganese.
Topics: Aged; Aluminum; Humans; Male; Manganese; Manganese Poisoning; Parkinson Disease | 1999 |
Aluminum-containing antacids as a cause of idiopathic Parkinson's disease.
Topics: Aluminum; Antacids; Humans; Models, Biological; Parkinson Disease; Stomach Ulcer | 1999 |
Activation of monoamine oxidase type-B by aluminum in rat brain homogenate.
Topics: Aluminum; Aluminum Compounds; Alzheimer Disease; Animals; Brain; Cell Extracts; Deamination; Dose-Response Relationship, Drug; Enzyme Activation; Kinetics; Lactates; Male; Monoamine Oxidase; Parkinson Disease; Phenethylamines; Rats; Rats, Wistar; Sodium Lactate; Thermodynamics | 1999 |
The relationship between Parkinson syndrome and vascular siderosis: an electron microprobe study.
Topics: Aged; Aluminum; Barium; Calcium; Cerebral Arterial Diseases; Electron Probe Microanalysis; Female; Globus Pallidus; Humans; Iron; Lead; Magnesium; Male; Manganese; Middle Aged; Parkinson Disease; Phosphorus; Potassium; Siderosis; Sulfur; Zinc | 1977 |
[Presence of aluminum and magnesium in the cerebral arteries and parenchyma of patients with striatonigral syndrome: study by Castaing's microprobe].
Topics: Aluminum; Calcium; Cerebral Arteries; Corpus Striatum; Electron Probe Microanalysis; Globus Pallidus; Humans; Iron; Magnesium; Parkinson Disease; Phosphorus; Putamen; Siderosis; Substantia Nigra; Syndrome; Vascular Diseases | 1976 |
Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
Topics: Aluminum; Humans; Iron; Lasers; Mass Spectrometry; Melanins; Neurons; Parkinson Disease; Reference Values; Substantia Nigra; Trace Elements | 1992 |
Calcium, magnesium and aluminum concentrations in Parkinson's disease.
Topics: Aged; Aluminum; Brain; Calcium; Female; Humans; Magnesium; Male; Parkinson Disease | 1992 |
[Aluminum deposition in the central nervous system tissues of patients with Parkinson's disease].
Topics: Aged; Aluminum; Brain Chemistry; Caudate Nucleus; Female; Globus Pallidus; Humans; Male; Neutron Activation Analysis; Parkinson Disease; Substantia Nigra | 1991 |
Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Topics: Aged; Aged, 80 and over; Aluminum; Brain; Electron Probe Microanalysis; Female; Humans; Iron; Male; Melanins; Middle Aged; Parkinson Disease; Substantia Nigra; Supranuclear Palsy, Progressive | 1991 |
Neurodegeneration and the nose.
Topics: Alcohol Amnestic Disorder; Aluminum; Alzheimer Disease; Humans; Nerve Degeneration; Olfactory Nerve; Olfactory Pathways; Parkinson Disease; Smell | 1990 |
Histochemical and X-ray microanalytical localization of aluminum in amyotrophic lateral sclerosis and parkinsonism-dementia of Guam.
Topics: Adolescent; Adult; Aged; Aluminum; Amyotrophic Lateral Sclerosis; Dementia; Electron Probe Microanalysis; Female; Flavonoids; Guam; Histocytochemistry; Humans; Male; Middle Aged; Parkinson Disease; Staining and Labeling | 1988 |
Intraneuronal co-localization of silicon with calcium and aluminum in amyotrophic lateral sclerosis and parkinsonism with dementia of Guam.
Topics: Aluminum; Amyotrophic Lateral Sclerosis; Calcium; Dementia; Guam; Hippocampus; Histocytochemistry; Humans; Neurons; Parkinson Disease; Silicon | 1986 |
Aluminum neurotoxicity--potential role in the pathogenesis of neurofibrillary tangle formation.
Topics: Aluminum; Alzheimer Disease; Animals; Brain; Dementia; Guam; Humans; Intracellular Membranes; Lasers; Nervous System; Neurofibrils; Parkinson Disease | 1986 |
3-methoxy-4-hydroxyphenylalanine (3-O-methyldopa) in plasma during oral L-dopa therapy of patients with Parkinson's disease.
Topics: Administration, Oral; Aluminum; Buffers; Chromatography; Chromatography, Ion Exchange; Dihydroxyphenylalanine; Fasting; Humans; Hydrogen-Ion Concentration; Kinetics; Methods; Methyldopa; Parkinson Disease; Phenylacetates; Spectrometry, Fluorescence | 1972 |
Neurofibrillary pathology.
Topics: Aluminum; Amyotrophic Lateral Sclerosis; Animals; Autopsy; Biopsy; Brain; Brain Diseases; Central Nervous System Diseases; Colchicine; Dementia; Encephalitis, Arbovirus; Humans; Microscopy, Electron; Middle Aged; Neurofibrils; Parkinson Disease; Podophyllin; Vinblastine; Vincristine | 1970 |
Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac).
Topics: Aluminum; Bone Neoplasms; Dihydroxyphenylalanine; Dopamine; Electrophoresis; Ethylenediamines; Fluorometry; Ganglioneuroma; Humans; Hyperkinesis; Methods; Neoplasm Metastasis; Neuroblastoma; Oxides; Paper; Parkinson Disease; Phenylacetates | 1971 |
Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
Topics: Aged; Aluminum; Chromatography; Chromatography, Ion Exchange; Colorimetry; Dihydroxyphenylalanine; Dopamine; Electrophoresis; Epinephrine; Female; Fluorometry; Humans; Male; Methods; Middle Aged; Norepinephrine; Normetanephrine; Oxides; Paper; Parkinson Disease; Phenylacetates; Vanilmandelic Acid | 1971 |